Drug release profiles of ophthalmic formulations. 1. Instrumentation

Area of Science:

• Ophthalmic drug delivery
• Pharmacokinetics
• Analytical chemistry

Background:

• Accurate measurement of drug release from ophthalmic dosage forms is crucial for effective therapy.
• Existing methods may not fully replicate the physiological conditions of the human eye.
• Understanding in vivo drug release kinetics is essential for optimizing ophthalmic formulations.

Purpose of the Study:

• To describe a novel in vitro experimental method for measuring time-release profiles of ophthalmic drugs.
• To simulate key physiological conditions of the human precorneal tear reservoir in vitro.
• To enable accurate modeling of drug release kinetics from various ophthalmic dosage forms.

Main Methods:

• Developed an in vitro system mimicking the small volume (8-30 microL) and slow tear turnover of the human precorneal reservoir.
• Employed near-continuous downstream drug concentration analysis to capture complete release profiles.
• Applied the method to study drug release kinetics from controlled-release formulations, including gels and suspensions.

Main Results:

• The experimental method successfully measured time-release profiles of drugs from ophthalmic dosage forms.
• The in vitro conditions closely represented in vivo physiological parameters.
• The generated release profiles were suitable for kinetic modeling and analysis.

Conclusions:

• The described in vitro method provides a reliable and physiologically relevant approach for evaluating ophthalmic drug release.
• This technique facilitates the study of drug release kinetics from diverse ophthalmic formulations.
• The method offers a valuable tool for the development and optimization of ophthalmic drug delivery systems.